Related Experiment Video
Updated: Sep 6, 2025

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
Structural Basis for Dityrosine-Mediated Inhibition of α-Synuclein Fibrillization
Cagla Sahin1,2, Eva Christina Østerlund3, Nicklas Österlund4
1Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.
Mild oxidation of alpha-synuclein (α-Syn) causes structural compaction, inhibiting amyloid formation. This suggests a protective role for oxidation against Parkinson
Area of Science:
- Biochemistry
- Neuroscience
- Structural Biology
Background:
- Alpha-synuclein (α-Syn) aggregation into plaques is a hallmark of Parkinson's disease.
- Oxidative stress is known to affect α-Syn structure and aggregation, but the mechanisms are unclear.
Purpose of the Study:
- To investigate the chemical and physical effects of mild oxidation on monomeric α-Syn.
- To understand how oxidation influences α-Syn self-assembly and amyloid formation.
Main Methods:
- Biophysical techniques
- Small-angle X-ray scattering (SAXS)
- Native ion mobility mass spectrometry (IM-MS)
Main Results:
- Mild oxidation induces intramolecular dityrosine cross-linkages in α-Syn.
- Oxidation causes a significant compaction of the α-Syn monomer (by a factor of √2).
- Oxidation-induced compaction inhibits ordered self-assembly and amyloid formation via steric hindrance.
Conclusions:
- Mild oxidation plays a crucial role in preventing α-Syn amyloid formation.
- The findings provide insights into the protective mechanisms against Parkinson's disease pathology.
More Related Videos
08:40Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
Published on: June 23, 2022
15:04Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...